Determinants of Medication Adherence for Pulmonary Tuberculosis Patients During Continuation Phase in Dalian, Northeast China

References

• World Health Organization. Global tuberculosis report 2019. Geneva, Switzerland: World Health Organization;2019. WHO/CDS/TB/2019.15.
   Google Scholar
• Harper I. Extreme condition, extreme measures? Compliance, drug resistance, and the control of tuberculosis. Anthropol Med. 2010;17(2):201–214. doi:10.1080/13648470.2010.493606
   PubMedGoogle Scholar
• Xu CH, Jeyashree K, Shewade HD, et al. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019;8(1):46. doi:10.1186/s40249-019-0564-2
   Google Scholar
• Menzies NA, Gomez GB, Bozzani F, et al. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. Lancet Glob Health. 2016;4(11):e816–e826. doi:10.1016/S2214-109X(16)30265-0
   Web of Science ®Google Scholar
• Mekonnen HS, Azagew AW. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res Notes. 2018;11(1):691. doi:10.1186/s13104-018-3789-4
   Google Scholar
• Adane AA, Alene KA, Koye DN, Zeleke BM. Non-adherence to anti-tuberculosis treatment and determinant factors among patients with tuberculosis in Northwest Ethiopia. PLoS One. 2013;8(11):6. doi:10.1371/journal.pone.0078791
   Web of Science ®Google Scholar
• Martinez L, Shen Y, Mupere E, Kizza A, Hill PC, Whalen CC. Transmission of Mycobacterium tuberculosis in households and the community: a systematic review and meta-analysis. Am J Epidemiol. 2017;185(12):1327–1339. doi:10.1093/aje/kwx025
   Web of Science ®Google Scholar
• Yao S, Huang WH, van den Hof S, et al. Treatment adherence among sputum smear-positive pulmonary tuberculosis patients in mountainous areas in China. BMC Health Serv Res. 2011;11(1):341. doi:10.1186/1472-6963-11-341
   PubMed Web of Science ®Google Scholar
• Lei X, Huang K, Liu Q, Jie YF, Tang SL. Are tuberculosis patients adherent to prescribed treatments in China? Results of a prospective cohort study. Infect Dis Poverty. 2016;5(1):38. doi:10.1186/s40249-016-0134-9
   PubMed Web of Science ®Google Scholar
• Zhou C, Chu J, Liu J, et al. Adherence to tuberculosis treatment among migrant pulmonary tuberculosis patients in Shandong, China: a quantitative survey study. PLoS One. 2012;7(12):e52334. doi:10.1371/journal.pone.0052334
   PubMed Web of Science ®Google Scholar
• Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Lomakina OB, Kourbatova EV. Impact of socio-psychological factors on treatment adherence of TB patients in Russia. Tuberculosis (Edinb). 2008;88(5):495–502. doi:10.1016/j.tube.2008.03.004
   Web of Science ®Google Scholar
• Janakan N, Seneviratne R. Factors contributing to medication noncompliance of newly diagnosed smear-positive pulmonary tuberculosis patients in the district of Colombo, Sri Lanka. Asia Pac J Public Health. 2008;20(3):214–223. doi:10.1177/1010539508316974
   Web of Science ®Google Scholar
• Muture BN, Keraka MN, Kimuu PK, Kabiru EW, Ombeka VO, Oguya F. Factors associated with default from treatment among tuberculosis patients in Nairobi province, Kenya: a case control study. BMC Public Health. 2011;11(1):696. doi:10.1186/1471-2458-11-696
   Web of Science ®Google Scholar
• Theron G, Peter J, Zijenah L, et al. Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study. BMC Infect Dis. 2015;15(1):253. doi:10.1186/s12879-015-0964-2
   PubMed Web of Science ®Google Scholar
• Skinner D, Claassens M. It’s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infect Dis. 2016;16(1):712. doi:10.1186/s12879-016-2054-5
   Web of Science ®Google Scholar
• Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238. doi:10.1371/journal.pmed.0040238
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhao M, Wang Y, et al. Non-adherence to anti-tuberculosis treatment among internal migrants with pulmonary tuberculosis in Shenzhen, China: a cross-sectional study. BMC Public Health. 2015;15(1):474. doi:10.1186/s12889-015-1789-z
   PubMed Web of Science ®Google Scholar
• Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196(4286):129–136. doi:10.1126/science.847460
   PubMed Web of Science ®Google Scholar
• Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980;137(5):535–544.
   PubMed Web of Science ®Google Scholar
• Ogundele OA, Moodley D, Pillay AW, Seebregts CJ. An ontology for factors affecting tuberculosis treatment adherence behavior in sub-Saharan Africa. Patient Prefer Adherence. 2016;10:669–681. doi:10.2147/PPA.S96241
   Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.07572.x
   PubMed Web of Science ®Google Scholar
• Valencia S, Leon M, Losada I, Sequera VG, Fernandez Quevedo M, Garcia-Basteiro AL. How do we measure adherence to anti-tuberculosis treatment? Expert Rev Anti Infect Ther. 2017;15(2):157–165. doi:10.1080/14787210.2017.1264270
   PubMed Web of Science ®Google Scholar
• Bress AP, Bellows BK, King JB, et al. Cost-effectiveness of intensive versus standard blood-pressure control. N Engl J Med. 2017;377(8):745–755. doi:10.1056/NEJMsa1616035
   PubMed Web of Science ®Google Scholar
• Berlowitz DR, Foy CG, Kazis LE, et al. Effect of intensive blood-pressure treatment on patient-reported outcomes. N Engl J Med. 2017;377(8):733–744. doi:10.1056/NEJMoa1611179
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi:10.1001/archinte.166.10.1092
   PubMed Web of Science ®Google Scholar
• Xu M, Markstrom U, Lyu J, Xu L. Survey on tuberculosis patients in rural areas in China: tracing the role of stigma in psychological distress. Int J Environ Res Public Health. 2017;14(10):10. doi:10.3390/ijerph14101171
   Web of Science ®Google Scholar
• Li J, Munsiff SS, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis. 2010;14(4):e292–297. doi:10.1016/j.ijid.2009.05.007
   PubMed Web of Science ®Google Scholar
• Guix-Comellas EM, Rozas-Quesada L, Force-Sanmartin E, Estrada-Masllorens JM, Galimany-Masclans J, Noguera-Julian A. Influence of nursing interventions on adherence to treatment with antituberculosis drugs in children and young people: research protocol. J Adv Nurs. 2015;71(9):2189–2199. doi:10.1111/jan.12656
   Web of Science ®Google Scholar
• Costa E, Giardini A, Savin M, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015;9:1303–1314. doi:10.2147/PPA.S87551
   PubMed Web of Science ®Google Scholar
• Xin YJ, Xiang L, Jiang JN, Lucas H, Tang SL, Huang F. The impact of increased reimbursement rates under the new cooperative medical scheme on the financial burden of tuberculosis patients. Infect Dis Poverty. 2019;8(1):9. doi:10.1186/s40249-019-0575-z
   Google Scholar
• Duan WX, Zhang W, Wu CG, et al. Extent and determinants of catastrophic health expenditure for tuberculosis care in Chongqing municipality, China: a cross-sectional study. BMJ Open. 2019;9(4):10. doi:10.1136/bmjopen-2018-026638
   Web of Science ®Google Scholar
• Mao WH, Jiang WX, Hamilton C, et al. Over- and under-treatment of TB patients in Eastern China: an analysis based on health insurance claims data. Trop Med Int Health. 2019;24(9):1078–1087. doi:10.1111/tmi.13287
   PubMed Web of Science ®Google Scholar
• Lukoye D, Adatu F, Musisi K, et al. Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey. PLoS One. 2013;8(8):e70763. doi:10.1371/journal.pone.0070763
   PubMed Web of Science ®Google Scholar
• Wang K, Chen S, Wang X, et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China. Microb Drug Resist. 2014;20(4):294–300. doi:10.1089/mdr.2013.0145
   Web of Science ®Google Scholar
• Park S, Sentissi I, Gil SJ, et al. Medication event monitoring system for infectious tuberculosis treatment in Morocco: a retrospective cohort study. Int J Environ Res Public Health. 2019;16(3):412.
   Web of Science ®Google Scholar
• Williams G, Alarcon E, Jittimanee S, et al. Guidance for the implementation of best practice for the care of patients with tuberculosis. Int J Tuberc Lung Dis. 2008;12(3):236–240.
   Web of Science ®Google Scholar
• Hasker E, Khodjikhanov M, Sayfiddinova S, et al. Why do tuberculosis patients default in Tashkent City, Uzbekistan? A qualitative study. Int J Tuberc Lung Dis. 2010;14(9):1132–1139.
   Web of Science ®Google Scholar
• M’Imunya JM, Kredo T, Volmink J. Patient education and counselling for promoting adherence to treatment for tuberculosis. Cochrane Database Syst Rev. 2012;(5). doi:10.1002/14651858.CD006591.pub2.
   Web of Science ®Google Scholar
• Li Y, Zhang S, Zhang T, et al. Chinese health literacy scale for tuberculosis patients: a study on development and psychometric testing. BMC Infect Dis. 2019;19(1):545. doi:10.1186/s12879-019-4168-z
   Google Scholar
• Lonnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet. 2010;375(9728):1814–1829. doi:10.1016/S0140-6736(10)60483-7
   PubMed Web of Science ®Google Scholar
• Nieuwlaat R, Wilczynski N, Navarro T, et al. Interventions for enhancing medication adherence (Review). Cochrane Database Syst Rev. 2014;(11):CD000011.
   Web of Science ®Google Scholar
• Widjanarko B, Gompelman M, Dijkers M, van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence. 2009;3:231–238. doi:10.2147/ppa.s6020
   Web of Science ®Google Scholar
• Park CK, Shin HJ, Kim YI, et al. Predictors of default from treatment for tuberculosis: a single center case-control study in Korea. J Korean Med Sci. 2016;31(2):254–260. doi:10.3346/jkms.2016.31.2.254
   Web of Science ®Google Scholar
• Moro RN, Borisov AS, Saukkonen J, et al. Factors associated with noncompletion of latent tuberculosis infection treatment: experience from the PREVENT TB trial in the United States and Canada. Clin Infect Dis. 2016;62(11):1390–1400. doi:10.1093/cid/ciw126
   Web of Science ®Google Scholar
• Peltzer K, Naidoo P, Matseke G, Louw J, McHunu G, Tutshana B. Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry. 2012;12(1). doi:10.1186/1471-244X-12-89
   Google Scholar
• Guo YX, Xu XF, Zhang QZ, et al. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid/rifampicin-induced hepatotoxicity. Toxicol Mech Methods. 2015;25(5):382–387. doi:10.3109/15376516.2015.1033074
   PubMed Web of Science ®Google Scholar